Discover trends, market shifts, and competitive outlooks for the animal drug compounding industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
#What Is the Current and Projected Market Size of the Animal Drug Compounding Market Through 2034?
The market size of animal drug compounding has shown notable growth over the recent years. The market is projected to increase from $1.67 billion in 2024 to $1.79 billion in 2025, marking a compound annual growth rate (CAGR) of 7.2%. Factors such as regulatory environment, veterinary procedures, market understanding, finite commercial alternatives, and joint efforts in veterinary field have significantly contributed to this historic period’s growth.
In the coming years, the market size for animal drug compounding is projected to exhibit robust growth, expanding to $2.38 billion by 2029 at a Compound Annual Growth Rate (CAGR) of 7.4%. The anticipated growth over this period can be credited to factors such as regulatory advancements, patterns in pet ownership, specialized care for animals, the globalization of veterinary services, and improvements in veterinary medicine. Anticipated trends throughout the projection period include an emphasis on taste and palatability, a rising demand for specialized dosage forms, partnerships between veterinarians and compounding pharmacists, a focus on pain management solutions, and an expanding role in animal hospice care.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9964&type=smp
How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the Animal Drug Compounding Market?
The growth of the animal drug compounding market is predicted to be driven by an increase in animal adoption rates. Animal adoption typically involves obtaining pets from rescue organizations rather than buying them from breeders or pet stores. It’s common for these adopted pets to have existing health concerns or require medicines that aren’t available in regular forms, which necessitates the need for personalization of their prescriptions. As more people adopt pets and demand customized medication for these animals, the animal drug compounding market will likely expand. For example, a survey by Novuna, a financial services firm based in the UK, found that around 10,070 dogs were adopted in October 2023, indicating an 11.06% surge from 2022. Consequently, the escalating animal adoption rates are fueling the expansion of the animal drug compounding market.
Which Segments in the Animal Drug Compounding Offer the Most Growth?
The animal drug compounding market covered in this report is segmented –
1) By Animal Type: Companion Animals, Livestock Animals
2) By Product: Anti-Infective Agents, Anti-inflammatory Agents, Hormones And Substitutes, CNS Agents, Other Products
3) By Route Of Administration: Oral, Injectable, Topical, Other Routes Of Administration
4) By Application: Veterinary Hospitals, Veterinary Clinics, Veterinary Diagnostic Centers
Subsegments:
1) By Companion Animals: Dogs, Cats, Horses, Other Small Mammals
2) By Livestock Animals: Cattle, Swine, Poultry, Sheep, Goats
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=9964&type=smp
What Are the Fastest-Growing Geographies in the Animal Drug Compounding Market?
North America was the largest region in the animal drug compounding market in 2024. The regions covered in the animal drug compounding market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Are the Current Market Growth and Trends in the Animal Drug Compounding Industry?
Leading firms in the animal drug compounding sector are focusing on creating unique products, such as feline-friendly formulations, to boost the safety and efficacy of medications meant specifically for cats. These feline-friendly formulations are products ingeniously designed to be secure, potent, and attractive for cats. For example, in September 2024, a veterinary pharmaceutical company based in the US, Wedgewood, introduced compounded molnupiravir. It is an antiviral drug made exclusively for treating Feline Infectious Peritonitis (FIP) in cats. The product provides feline-friendly versions of molnupiravir, presented in diverse dosages ideal for various forms of FIP like effusive, non-effusive, neurological, and ocular. It requires the formulation of different dosages and flavors, such as tasteful oral oil suspensions and pills, to cater to the unique needs of every feline patient.
View the full report here:
https://www.thebusinessresearchcompany.com/report/animal-drug-compounding-global-market-report
What Are the Key Elements That Define the Animal Drug Compounding Market?
Animal drug compounding is defined as the process of mixing and altering the ingredients of multiple medicines to create a customized medicine to treat the specific needs of a single animal or multiple animals. It is used for providing medical treatment for animals and is a process that plays an important role in veterinary medicine.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9964
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
